Jay Giri, MD, MPH is an Interventional Cardiologist, Director of the Cardiovascular Catheterization Laboratories at the Hospital of the University of Pennsylvania, Director of the Penn Cardiovascular Outcomes, Quality & Evaluative Research Center, and Associate Professor at the Perelman School of Medicine.
His clinical interests include complex coronary artery intervention, venous thromboembolism, transcatheter aortic valve replacement, and endovascular denervation therapies. He conducts clinical outcomes and comparative effectiveness research related to emerging endovascular technologies and interventional pharmacotherapies, as well as health services and policy research related to cardiovascular medicine. He also leads several multi-site international clinical trials evaluating novel interventional therapies. Giri is the author of more than 300 original research manuscripts, invited reviews, textbook chapters, and editorials.
In 2017, he was selected as one of 12 interventional cardiologists worldwide with fewer than 10 years in practice for the Society for Cardiovascular Angiography & Interventions’ Emerging Leader Mentorship (ELM) Fellowship. He received the 2019 Transcatheter Therapeutics (TCT) Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award, given to one interventional cardiologist worldwide under age 40 for academic and clinical excellence.
Giri earned a Bachelor of Arts in Economics, a Master of Public Health, and a Doctor of Medicine from Northwestern University over seven years as a member of the accelerated Honors Program in Medical Education. He completed a residency in internal medicine at Massachusetts General Hospital and fellowships in cardiovascular diseases, coronary and structural heart intervention, and vascular medicine/intervention at the Hospital of the University of Pennsylvania and Massachusetts General Hospital.
